SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001851734-22-000712
Filing Date
2022-12-02
Accepted
2022-12-02 07:25:45
Documents
13
Period of Report
2022-11-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20221201_8k.htm   iXBRL 8-K 23271
  Complete submission text file 0001851734-22-000712.txt   146525

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arch-20221130.xsd EX-101.SCH 3602
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20221130_def.xml EX-101.DEF 10837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20221130_lab.xml EX-101.LAB 14481
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20221130_pre.xml EX-101.PRE 10883
7 EXTRACTED XBRL INSTANCE DOCUMENT arch20221201_8k_htm.xml XML 2412
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 221440273
SIC: 3841 Surgical & Medical Instruments & Apparatus